NCT02949778View on ClinicalTrials.gov

Quadratus Lumborum Block for Abdominoplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 7, 2016

Primary Completion Date

June 15, 2017

Study Completion Date

December 13, 2017

Conditions
Pain, PostoperativeAbdominoplasty
Interventions
PROCEDURE

QL-block

Bilateral quadratus lumborum block using either ropivacaine 3.75mg/ml or sodium chloride 0.9% is the intervention studied

DRUG

Ropivacaine

Ropivacaine 3.75mg/ml administered in QL-block as active treatment

DRUG

Sodium Chloride

Sodium chloride 9mg/mL administered in QL-Block as placebo

Trial Locations (1)

Unknown

Vestre Viken HT, Baerum Hospital, Sandvika

All Listed Sponsors
lead

Vestre Viken Hospital Trust

OTHER

NCT02949778 - Quadratus Lumborum Block for Abdominoplasty | Biotech Hunter | Biotech Hunter